Genetic variants increasing ANP (NPPA), but not BNP (NPPB), are associated with lower BP and reduced HTN risk, highlighting ANP as the primary natriuretic peptide influencing BP regulation in humans. The gene discussed is NPPB; the disease is hypertensive disorder.